PRO-CURE THERAPEUTICS
Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.
PRO-CURE THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Medical Pharmaceutical
Founded:
2001-01-01
Address:
York, York, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
44 1904 435 125
Email Addresses:
[email protected]
Total Funding:
2.24 M USD
Technology used in webpage:
OpenResty
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Investors List
Maven Capital Partners
Maven Capital Partners investment in Venture Round - Pro-Cure Therapeutics
SMH Venture Finance Limited
SMH Venture Finance Limited investment in Venture Round - Pro-Cure Therapeutics
Yorkshire Cancer Research
Yorkshire Cancer Research investment in Venture Round - Pro-Cure Therapeutics
Yorkshire Cancer Research
Yorkshire Cancer Research investment in Venture Round - Pro-Cure Therapeutics
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Venture Round - Pro-Cure Therapeutics